- Ticker
- ABIO
- Price
- 2.05
- Stock movement down
- -0.06 (-2.84%)
- Company name
- ARCA Biopharma Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Markedsværdi
- 29.54M
- Ent værdi
- -12.16M
- Pris/omsætning
- -
- Pris/bog
- 0.69
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- -
- Efterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års afkast
- -13.87%
- 3 års afkast
- -7.62%
- 5 års afkast
- -28.70%
- 10 års afkast
- -40.13%
Senest opdateret: 2023-03-22
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
28. oktober 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
2. august 2022
iO Charts is a Seeking Alpha partner
UDBYTTE
ABIO betaler ikke udbytte
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
2. august 2022
iO Charts is a Seeking Alpha partner
Activist is pushing ARCA biopharma to stop new developments and return cash to shareholders. Click here to learn more about ABIO stock.
3. maj 2022
iO Charts is a Seeking Alpha partner
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | - |
| Pris til egenkapital | 0.69 |
| EV i forhold til salg | - |
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
2. maj 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
18. april 2022
iO Charts is a Seeking Alpha partner
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 14.41M |
| EPS (TTM) | -1.00 |
| FCF pr. aktie (TTM) | -1.00 |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | 0.00 |
| Bruttofortjeneste (TTM) | 0.00 |
| Driftsindkomst (TTM) | -14.73M |
| Nettoindkomst (TTM) | -14.43M |
| EPS (TTM) | -1.00 |
| EPS (1 år frem) | - |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | - |
| Driftsmargin (TTM) | - |
| Fortjenstmargin (TTM) | - |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 43.94M |
| Nettotilgodehavender | 0.00 |
| Omsætningsaktiver i alt | 44.55M |
| Goodwill | 0.00 |
| Immaterielle aktiver | 0.00 |
| Ejendomme, anlæg og udstyr | 0.00 |
| Sum aktiver | 44.97M |
| Kreditor | 593.00K |
| Kortfristet/nuværende langsigtet gæld | 301.00K |
| Summen af kortfristede forpligtelser | 1.94M |
| Sum gæld | 2.24M |
| Aktionærernes egenkapital | 42.73M |
| Materielle nettoaktiver | 42.73M |
Likviditet
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
| Likviditet fra driften (TTM) | -14.37M |
| Investeringsudgifter (TTM) | 9.00K |
| Fri pengestrøm (TTM) | -14.37M |
| Udbetalt udbytte (TTM) | 0.00 |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | -33.77% |
| Afkast af aktiver | -32.09% |
| Afkast af investeret kapital | -33.77% |
| Kontant afkast af investeret kapital | -33.64% |
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
31. marts 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
14. marts 2022
iO Charts is a Seeking Alpha partner
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 2.10 |
| Daglig høj | 2.10 |
| Daglig lav | 2.05 |
| Daglig volumen | 15K |
| Højeste gennem alle tider | 5726700.00 |
| 1 års analytiker estimat | 7.00 |
| Beta | 1.64 |
| EPS (TTM) | -1.00 |
| Udbytte pr. aktie | - |
| Ex-div dato | 1 May 2006 |
| Næste dato for resultatpræsentation | 1 May 2023 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| ABIO | S&P500 | |
| Nuværende prisfald fra top notering | -100.00% | -17.92% |
| Højeste prisfald | -100.00% | -56.47% |
| Højeste efterår dato | 22 Mar 2023 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -93.88% | -11.51% |
| Gennemsnitlig tid til nyt højdepunkt | 280 days | 13 days |
| Maks. tid til nyt højdepunkt | 5809 days | 1805 days |
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
2. december 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
2. november 2021
iO Charts is a Seeking Alpha partner
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
29.54M
Markedsværdi kategori
Small-cap
Beskrivelse
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.
Personale
17
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Michael R. Bristow
Land
USA
By
Westminster
Aktietype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
28. oktober 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
16. september 2021
iO Charts is a Seeking Alpha partner
FORSTÅ FORRETNINGEN
Loading...
The following slide deck was published by ARCA biopharma, Inc.
23. august 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
9. august 2021
iO Charts is a Seeking Alpha partner
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic optionsWESTMINSTER, Colo., Feb. 24, 2023 (GLOBE NEWSWIRE...
24. februar 2023
We can readily understand why investors are attracted to unprofitable companies. For example, although...
3. februar 2023
WESTMINSTER, Colo., Dec. 19, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that James Flynn has joined its Board of Directors. “We are pleased to welcome James Flynn to ...
19. december 2022
Viewing insider transactions for ARCA biopharma, Inc.'s ( NASDAQ:ABIO ) over the last year, we see that insiders were...
14. november 2022
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic optionsWESTMINSTER, Colo., Oct. 28, 2022 (GLOBE NEWSWIRE...
28. oktober 2022
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., Aug. 02, 2022 (GLOBE NEWSWIR...
2. august 2022
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
18. juli 2022
WESTMINSTER, Colo., June 21, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that Jacob Ma-Weaver has joined its Board of Directors. “We are pleased to welcome Jacob Ma-We...
21. juni 2022
WESTMINSTER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that it has retained Ladenburg Thalmann & Co. Inc. to act as its financial advisor. In April 20...
5. maj 2022
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., May 02, 2022 (GLOBE NEWSWIRE...
2. maj 2022
Næste side
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
4. august 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
13. juli 2021
iO Charts is a Seeking Alpha partner